汎ぶどう膜炎治療の世界市場レポート 2024

汎ぶどう膜炎治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.6%の年間複合成長率（CAGR）で57億4,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化医療アプローチの採用、新たな治療法の出現、患者中心のケアへの注目の高まり、世界の健康への備えの取り組み、精密医療プログラム、ヘルスケア政策の変化に起因すると考えられます。予測期間中に予想される主な動向には、相乗効果をもたらす併用療法の使用、遠隔医療と遠隔モニタリングの普及、画像技術の進歩、ヘルスケアにおける人工知能の統合、調査活動における世界の協力の増加などが含まれます。

免疫抑制療法の導入拡大により、将来汎ぶどう膜炎治療市場の成長が促進されると予想されます。免疫抑制療法には、免疫系の反応を抑制する薬剤の使用が含まれ、ブドウ膜の炎症を軽減し、汎ぶどう膜炎を効果的に管理します。これらの治療法は、眼関連疾患の重症度を軽減する上で重要な役割を果たし、患者の転帰の改善と症状の軽減に貢献します。たとえば、2023年9月に英国の医学雑誌『ランセット』に掲載された研究では、免疫抑制療法が汎ぶどう膜炎の管理に顕著な有効性を示し、好ましい治療選択肢として免疫抑制療法の利用が増加傾向にあることが示されました。したがって、免疫抑制療法の採用の増加が、汎ぶどう膜炎治療市場の主要な原動力となっています。

外科的介入の進歩により、今後数年間で汎ぶどう膜炎治療市場の成長が促進されると予想されます。外科的処置は、重度の汎ぶどう膜炎の場合に重要な治療手段を提供し、合併症に対処し、視力の回復を助けます。これらの介入には、硝子体切除術、眼内の硝子体ゲルの外科的除去、汎ぶどう膜炎関連の視力障害を管理するためのデバイスまたは人工眼内レンズの移植などの技術が含まれます。たとえば、米国眼科学会が2023年6月に発表した臨床報告書では、汎ぶどう膜炎合併症の治療において革新的な外科的アプローチが有望な結果を示しており、症状の管理における外科的介入への依存が高まっていることを示しています。したがって、外科治療の進歩が汎ぶどう膜炎治療市場の成長を推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の汎ぶどう膜炎治療市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗炎症
• 抗菌薬
• 免疫療法と標的療法
• 世界の汎ぶどう膜炎治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 外用
• 世界の汎ぶどう膜炎治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 在宅ケア
• 専門クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の汎ぶどう膜炎治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の汎ぶどう膜炎治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 汎ぶどう膜炎治療市場の競合情勢
• 汎ぶどう膜炎治療市場の企業プロファイル
  • Pfizer Inc.
  • Johnson and Johnson Pvt. Ltd.
  • Bausch Health Companies Inc.
  • AbbVie Inc.
  • Novartis AG

第31章 その他の大手および革新的な企業

• Bristol-Myers Squibb Company
• Hoffmann-La Roche Ltd.
• Allergan Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Daiichi Sankyo Company Ltd.
• Horizon Therapeutics plc
• Hikma Pharmaceuticals PLC
• Santen Pharmaceutical Co. Ltd.
• Jubilant Life Sciences Ltd.
• HanAll Biopharma Inc.
• Xbrane Biopharma AB
• Alimera Science Inc.
• Ocular Therapeutix Inc.
• EyeGate Pharmaceuticals Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Panuveitis represents a severe inflammation affecting all layers of the eye's uvea, encompassing the iris, ciliary body, and choroid, with potential repercussions on the retina, vitreous humor, optic nerve, or eye lens. Timely and effective panuveitis treatment is crucial to mitigate inflammation, alleviate symptoms, and prevent vision loss or complications associated with the condition.

The primary drug classes employed in panuveitis treatment include anti-inflammatory medications, antimicrobial drugs, immunotherapy, and targeted therapies. Anti-inflammatory agents are substances or treatments specifically designed to reduce inflammation within the body. These therapeutic interventions can be administered through various routes, including oral and topical applications. Panuveitis treatments are utilized by diverse end-users such as hospitals, home care services, specialty clinics, and others.

The panuveitis treatment market research report is one of a series of new reports from The Business Research Company that provides panuveitis treatment market statistics, including panuveitis treatment industry global market size, regional shares, competitors with a panuveitis treatment market share, detailed panuveitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the panuveitis treatment industry. This panuveitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panuveitis treatment market size has grown rapidly in recent years. It will grow from $3.6 billion in 2023 to $3.98 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth observed during the historic period can be attributed to several factors, including the increased prevalence of uveitis, heightened awareness leading to early diagnosis, advancements in drug delivery systems, advocacy initiatives by patient groups, and support from government entities along with regulatory approvals.

The panuveitis treatment market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, the emergence of novel therapeutic modalities, an increased focus on patient-centric care, global health preparedness initiatives, precision medicine programs, and changes in healthcare policies. Key trends expected during the forecast period encompass the use of combination therapies for synergistic effects, the widespread adoption of telemedicine and remote monitoring, advancements in imaging technologies, the integration of artificial intelligence in healthcare, and increased global collaborations in research efforts.

The expanding adoption of immunosuppressive therapy is expected to drive the growth of the panuveitis treatment market in the future. Immunosuppressive therapy involves the use of medications that suppress the immune system's response, reducing inflammation in the uvea and managing panuveitis effectively. These therapies play a vital role in mitigating the severity of eye-related diseases, contributing to improved patient outcomes and alleviating symptoms. For instance, in a study published in September 2023 in The Lancet, a UK-based medical journal, immunosuppressive therapies demonstrated significant effectiveness in managing panuveitis, showcasing an increasing trend in their utilization as a preferred treatment option. Therefore, the growing adoption of immunosuppressive therapy is a key driver for the panuveitis treatment market.

Advancements in surgical interventions are anticipated to fuel the growth of the panuveitis treatment market in the coming years. Surgical procedures offer crucial treatment avenues for severe cases of panuveitis, addressing complications and aiding in restoring vision. These interventions encompass techniques such as vitrectomy, surgical removal of the vitreous gel in the eye, and implantation of devices or artificial intraocular lenses to manage panuveitis-related vision impairments. For example, in a clinical report published in June 2023 by the American Academy of Ophthalmology, innovative surgical approaches have shown promising outcomes in treating panuveitis complications, signifying a growing reliance on surgical interventions for managing the condition. Hence, advancements in surgical treatments are propelling the growth of the panuveitis treatment market.

The substantial financial burden posed by the high treatment costs stands as a significant impediment to the growth of the panuveitis market in the forecast period. The expenses associated with panuveitis treatment, inclusive of biologic agents, hospitalizations, outpatient visits, and specialized medical supervision, contribute to the elevated financial burden faced by patients. For instance, as reported in April 2023 by the National Library of Medicine, the comprehensive expenses for medications, surgeries, intravitreal implants, and hospital care collectively amount to an average cost of $69,300 for patients undergoing panuveitis treatment. This considerable financial requirement poses a significant challenge and restrains market growth.

Prominent enterprises engaged in the panuveitis treatment market are directing their efforts towards the development of innovative therapeutic solutions such as Xipere, aimed at providing enhanced and dependable services to their clientele. Xipere (triamcinolone acetonide) represents a corticosteroid administered via suprachoroidal injection to address macular edema induced by ocular inflammation. For instance, in February 2022, Clearside Biomedical Inc., a distinguished biopharmaceutical entity specializing in advanced drug delivery solutions for ocular diseases, introduced Xipere for treating macular edema linked to uveitis and panuveitis in the United States. Being the pioneering approved therapy containing triamcinolone acetonide, Xipere offers a preservative-free, sterile formulation designed specifically for suprachoroidal administration, utilizing Clearside's proprietary microinjector intended for the suprachoroidal space (SCS).

In March 2021, Affibody AB, a biotechnology firm headquartered in Sweden and specializing in tailored therapies for uveitis-related conditions, established a strategic collaboration with Inmagene Biopharmaceuticals. This collaborative effort aimed to introduce izokibep, an interleukin-17 (IL-17) blocker, into the phase 2 clinical development stage for non-infectious intermediate, posterior, and pan-uveitis. Izokibep received approval from the Food and Drug Administration (FDA), a governmental regulatory agency in the United States. Inmagene Biopharmaceuticals, situated in China, is a clinical-stage biotech enterprise concentrating on the development of innovative treatments for immunological and inflammatory disorders, notably panuveitis.

Major companies operating in the panuveitis treatment market report are Pfizer Inc., Johnson and Johnson Pvt. Ltd., Bausch Health Companies Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Allergan Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Ltd., Horizon Therapeutics plc, Hikma Pharmaceuticals PLC, Santen Pharmaceutical Co. Ltd., Jubilant Life Sciences Ltd., HanAll Biopharma Inc., Xbrane Biopharma AB, Alimera Science Inc., Ocular Therapeutix Inc., EyeGate Pharmaceuticals Inc., Eyepoint Pharmaceuticals Inc., Graybug Vision Inc., Xoma Corporation, Tarsier Pharma Ltd., Vintage Labs Pvt. Ltd., Icon Bioscience Inc., Aciont Inc., Clearside Biomedical Inc., Aldeyra Therapeutics Inc.

North America was the largest region in the panuveitis treatment market in 2023. The regions covered in the panuveitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the panuveitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The panuveitis treatment market consists of revenues earned by entities by providing services such as immunosuppressive therapy, adjunctive therapies, and laser therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The panuveitis treatment market also includes sales of corticosteroids, biogenic agents, and intravitreal implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panuveitis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panuveitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panuveitis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panuveitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Class: Anti-Inflammatory; Antimicrobial Drugs; Immunotherapy And Targeted Therapies
• 2) By Route of Administration: Oral; Topical
• 3) By End Users: Hospitals; Home Care; Specialty Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Pvt. Ltd.; Bausch Health Companies Inc.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Panuveitis Treatment Market Characteristics

3. Panuveitis Treatment Market Trends And Strategies

4. Panuveitis Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Panuveitis Treatment Market Size and Growth

• 5.1. Global Panuveitis Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Panuveitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Panuveitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Panuveitis Treatment Market Segmentation

• 6.1. Global Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Anti-Inflammatory
• Antimicrobial Drugs
• Immunotherapy And Targeted Therapies
• 6.2. Global Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Topical
• 6.3. Global Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Home Care
• Speciality Clinics
• Other End Users

7. Panuveitis Treatment Market Regional And Country Analysis

• 7.1. Global Panuveitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Panuveitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Panuveitis Treatment Market

• 8.1. Asia-Pacific Panuveitis Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Panuveitis Treatment Market

• 9.1. China Panuveitis Treatment Market Overview
• 9.2. China Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Panuveitis Treatment Market

• 10.1. India Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Panuveitis Treatment Market

• 11.1. Japan Panuveitis Treatment Market Overview
• 11.2. Japan Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Panuveitis Treatment Market

• 12.1. Australia Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Panuveitis Treatment Market

• 13.1. Indonesia Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Panuveitis Treatment Market

• 14.1. South Korea Panuveitis Treatment Market Overview
• 14.2. South Korea Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Panuveitis Treatment Market

• 15.1. Western Europe Panuveitis Treatment Market Overview
• 15.2. Western Europe Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Panuveitis Treatment Market

• 16.1. UK Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Panuveitis Treatment Market

• 17.1. Germany Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Panuveitis Treatment Market

• 18.5. France Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Panuveitis Treatment Market

• 19.9. Italy Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Panuveitis Treatment Market

• 20.13. Spain Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Panuveitis Treatment Market

• 21.1. Eastern Europe Panuveitis Treatment Market Overview
• 21.2. Eastern Europe Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Panuveitis Treatment Market

• 22.1. Russia Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Panuveitis Treatment Market

• 23.1. North America Panuveitis Treatment Market Overview
• 23.2. North America Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Panuveitis Treatment Market

• 24.1. USA Panuveitis Treatment Market Overview
• 24.2. USA Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Panuveitis Treatment Market

• 25.1. Canada Panuveitis Treatment Market Overview
• 25.2. Canada Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Panuveitis Treatment Market

• 26.1. South America Panuveitis Treatment Market Overview
• 26.2. South America Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Panuveitis Treatment Market

• 27.1. Brazil Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Panuveitis Treatment Market

• 28.1. Middle East Panuveitis Treatment Market Overview
• 28.2. Middle East Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Panuveitis Treatment Market

• 29.1. Africa Panuveitis Treatment Market Overview
• 29.2. Africa Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Panuveitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Panuveitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Panuveitis Treatment Market Competitive Landscape
• 30.2. Panuveitis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson and Johnson Pvt. Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bausch Health Companies Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Panuveitis Treatment Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. Hoffmann-La Roche Ltd.
• 31.3. Allergan Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Regeneron Pharmaceuticals Inc.
• 31.6. Daiichi Sankyo Company Ltd.
• 31.7. Horizon Therapeutics plc
• 31.8. Hikma Pharmaceuticals PLC
• 31.9. Santen Pharmaceutical Co. Ltd.
• 31.10. Jubilant Life Sciences Ltd.
• 31.11. HanAll Biopharma Inc.
• 31.12. Xbrane Biopharma AB
• 31.13. Alimera Science Inc.
• 31.14. Ocular Therapeutix Inc.
• 31.15. EyeGate Pharmaceuticals Inc.

32. Global Panuveitis Treatment Market Competitive Benchmarking

33. Global Panuveitis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Panuveitis Treatment Market

35. Panuveitis Treatment Market Future Outlook and Potential Analysis

• 35.1 Panuveitis Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Panuveitis Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Panuveitis Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer